- Senior Managing Director
- T: +44 20 3727 1512
- F: +44 20 3727 1007
- 200 Aldersgate
- Aldersgate Street
- London, EC1A 4HD
- United Kingdom
- T: +44 20 3727 1000
- F: +44 20 3727 1007
- BSc (Hons) Management Science, UMIST, 1998
- Chartered Accountant
Navin Waghe is a Senior Managing Director in the FTI Consulting Economic and Financial Consulting practice based in London. Navin joined FTI Consulting in April 2011.
Prior to FTI Consulting, Navin Waghe joined LECG in January 2004 having spent five years working for PricewaterhouseCoopers, in their assurance and business advisory department where he became a fully qualified Chartered Accountant. Navin has worked on a variety of clients within the Financial Services sector leading teams on audits and various special work, with particular emphasis on Insurance, Reinsurance and Investment Management.
Navin has extensive experience of working for a range of clients across different sectors. He is considered an Expert specialising in providing advice in relation to assessing losses, valuation, pricing, industry frameworks, regulatory reviews, and cost allocation.
Navin has 12 years’ experience performing financial assessments and managing valuations in a variety of contexts, in particular in dispute contexts, for expert determination, litigation, and arbitration purposes. He has worked on matters before the UK High Court, the AAA, UNCITRAL and ICC arbitration forums, the Upper Tax Tribunal, and in mediation.
Navin’s project experience has included a number of complex negotiation and damages projects in a litigation/arbitration setting. His roles have involved acting as the Expert and the production of independent expert reports for submission to government departments, competition commissions, courts, arbitral panels, and regulatory bodies.
Additionally, Navin is an expert on providing competition and regulatory advice, particularly in relation to pricing issues, price controls, cost allocation and accounting separation.
Navin has led teams in relation profitability and excessive pricing cases in the Healthcare, Technology, and Financial Services sectors. In addition, to understanding the relevant tests these competition investigations have focused on the appropriate pricing considering the treatment been of specific capital and operating expenditure including R&D costs, intangible assets, IT costs, joint and common costs.